METHOD FOR IDENTIFYING DIABETIC FETOPATHY OF THE FETUS Russian patent published in 2022 - IPC G01N33/68 G01N33/543 A61B5/145 

FIELD: medicine.

SUBSTANCE: invention relates to the field of clinical diagnostics. Proposed is a method for identifying diabetic fetopathy of the fetus, including determining the type of diabetes mellitus in the mother, taking a blood sample of the mother, preparing the blood sample of the mother' resulting in an analyte, determining the value of concentration of at least one marker of diabetic fetopathy of the fetus in the analyte, wherein a protein selected from the group consisting of CEACAM1, and/or CNDP1, and/or CRP is used as a marker of diabetic fetopathy of the fetus in the analyte, and comparing the resulting value of concentration of the marker of diabetic fetopathy of the fetus in the analyte with the reference value.

EFFECT: invention provides an increase in the accuracy of analysis in diagnostics of diabetic fetopathy of the fetus and an expansion of the range of existing methods for analysis in diagnostics of diabetic fetopathy of the fetus.

2 cl, 7 tbl, 6 ex